返回
Zhaoke Ophthalmology Ltd（06622.HK）價格
06622.HK 股價走勢圖
ZHAOKE OPHTH-B (06622.HK)
Zhaoke Ophthalmology Ltd
HK$3.46
-0.57%
$-0.02
休市： Feb 13, 16:00:00 HKT
暫無資料關鍵數據
前收市價
$3.47
開盤價
$3.48
當日範圍
$3.4 - $3.5
52週區間
$1.26 - $4.6
交易量
--
平均成交量
1.0M
每股盈餘 (TTM)
-0.56
股息收益率
--
市值
$1.8B
什麼是 ZHAOKE OPHTH-B？
Zhaoke Ophthalmology Ltd. operates as holding company, which engages in the provision of ophthalmic pharmaceuticals. The company is headquartered in Guangzhou, Guangdong and currently employs 270 full-time employees. The company went IPO on 2021-04-29. The product pipelines primarily include NVK002 (Atropine) for myopia, CsA Ophthalmic Gel for DED and TAB014 (Bevacizumab) for wAMD. The products are primarily uses to treat eye diseases across both the front and the back of the eye, including dry eye disease (DED), myopia, presbyopia, wet age-related macular degeneration (wAMD) and diabetic macular edema (DME), glaucoma and corneal epithelial dysfunction (CED). The firm conducts its business in the domestic market and overseas markets.